463

Compound name
Leniolisib
Alt Name
CDZ173
Compound Image
Leniolisib.png
SMILES
CCC(N(CC1)C[C@H]1NC2=C(C3)C(CCN3C4=CC(C(F)(F)F)=C(OC)N=C4)=NC=N2)=O
MW
450.50
Brutto
C21H25F3N6O2
InChI
InChI=1S/C21H25F3N6O2/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28)/t13-/m0/s1
InChI Key
MWKYMZXCGYXLPL-ZDUSSCGKSA-N
Approval Jurisdiction
2019 FDA
Approved for clinical use
APDS PASLI Disease
CAS
1354690-24-6
PubChem CID
57495353
Action
PI3Kδ
Approved Drug List
1
Commercial Vendor
Novartis